Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial (Q45893712)
Jump to navigation
Jump to search
scientific article published on 4 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial |
scientific article published on 4 November 2015 |
Statements
1 reference
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial (English)
1 reference
Cliona Rooney
1 reference
Helen Heslop
1 reference
Nabil Ahmed
1 reference
Vita Brawley
1 reference
Meenakshi Hegde
1 reference
Kevin Bielamowicz
1 reference
Amanda Wakefield
1 reference
Alexia Ghazi
1 reference
Aidin Ashoori
1 reference
Oumar Diouf
1 reference
Claudia Gerken
1 reference
Daniel Landi
1 reference
Mamta Kalra
1 reference
Zhongzhen Yi
1 reference
Gianpietro Dotti
1 reference
Adrian Gee
1 reference
Stephen Gottschalk
1 reference
Suzanne Powell
1 reference
Robert Grossman
1 reference
Winfried Wels
1 reference
Yzonne Kew
1 reference
David Baskin
1 reference
Jonathan Zhang
1 reference
Pamela New
1 reference
John Hicks
1 reference
4 November 2015
1 reference
1 reference
3
1 reference
Suppl 2
1 reference
O11-O11
1 reference
Identifiers
1 reference
1 reference